Perenterol Lyo-Sol, polvere per sospensione orale - 14 Swissmedic Key 68559002 Registration Holder Zambon Svizzera SA Name Perenterol Lyo-Sol, polvere per sospensione orale Date of registration 16.05.2023 Introduction of Sequence 16.05.2023 ATC-Classification Saccharomyces Boulardii (A07FA02) Revision date WHO WHO-DDD Valid until 15.05.2028 Index Therapeuticus (BSV) Show package size 14 Index Therapeuticus (Swissmedic) 04.09. Description Swissmedic categorie. D SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680685590022 Medication Code Phytoarzneimittel Pharmacode Disponibility
Composition Polvere: saccharomyces boulardii cryodesiccatus (Saccharomyces boulardii CNCM I-745) 250 mg corresp. cellulae vivae 2*10^9 CFU, lactosum monohydricum 32.50 mg, pro vitro.
Soluzione: fructosum 1520.0 mg, acidum citricum, aromatica (Beerenaroma) cum propylenglycolum 10.08 mg et alcohol benzylicus 1.2 mg et ethanolum 4.48 mg, E 202, natrii benzoas 8.0 mg corresp. natrium 1.272 mg, aqua purificata, ad solutionem pro 8 ml. Packungsbestandteile Galenic Form polvere per sospensione orale Excipiens Active Agent Dose additional_information Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg correspond Cellulae Vivae 2 Polvere
Inactive agents Dose Lactose Monohydrate 32.5 mg
Galenic Form polvere per sospensione orale Excipiens Inactive agents Dose additional_information Citric Acid Alcohol Benzylicus 1.2mg / 8ml Aqua Purificata Aromatica (Beerenaroma) cum Propylenglycolum 10.08mg / 8ml E 202 conserv. Ethanol 4.48mg / 8ml Fructosum 1520mg / 8ml Soluzione Sodium Benzoate 8mg / 8ml
Source Data was imported : 08.06.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
